Back to insights
Growth Credit, News

Eucalyptus sells to New York-listed healthcare giant in $1.6b deal

OneVentures
17.04.20261 min read

Read the full article: Australian Financial Review

Related insights

27 October 2026

OneVentures

OneVentures appoints new global director, capital formation

Read the full article: InvestorDaily
investordaily.com.au/oneventures-appoints-new-global-director-capital-formation/

16 October 2026

OneVentures

Investors flock to tax-free venture capital funds after budget change


Sarah Meibusch, OneVentures Partner & Head of Healthcare

07 September 2026

Healthcare

Big pharma eyes Australian biotech as $300b patent cliff looms


View all